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Abstract
Objectives: Attendance at a specialist multidisciplinary motor neurone disease (MND) clinic is associated with improved
survival and may also improve quality of life and reduce hospital admissions. However, patients struggle to travel to clinic
and may experience difficulties between clinic visits that may not be addressed in a timely manner. We wanted to explore
how we could improve access to specialist MND care.Methods:We adopted an iterative, user-centered co-design approach,
collaborating with those with experience of providing and receiving MND care including patients, carers, clinicians, and
technology developers. We explored the unmet needs of those living with MND, how they might be met through service
redesign and through the use of digital technologies. We developed a new digital solution and performed initial testing with
potential users including clinicians, patients, and carers. Results: We used these findings to develop a telehealth system
(TiM) using an Android app into which patients and carers answer a series of questions about their condition on a weekly
basis. The questions aim to capture all the physical, emotional, and social difficulties associated with MND. This
information is immediately uploaded to the internet for review by the MND team. The data undergoes analysis in order to
alert clinicians to any changes in a patient or carer’s condition. Conclusions: We describe the benefits of developing a novel
digitally enabled service underpinned by participatory design. Future trials must evaluate the feasibility and acceptability of
the TiM system within a clinical environment.
Keywords: Motor neurone disease, amyotrophic lateral sclerosis, multidisciplinary, telehealth, telemedicine, technology
Background
Motor neurone disease (MND) causes a range of
complications including limb weakness, dysphagia,
dysarthria, and respiratory failure (1). Patients with
MND (which includes those with amyotrophic
lateral sclerosis, primary lateral sclerosis, and pro-
gressive muscular atrophy) require substantial help
with their activities of daily living. This is usually
provided by informal carers who, along with
patients, also experience significant physical, emo-
tional, and financial burden (2). It is recommended
that MND care is provided by a multidisciplinary
team of specialists who can address the complex
and changing biopsychosocial needs of patients and
their carers in order to maximize survival and
quality of life (3). Attendance at a multidisciplinary
clinic (MDC) is associated with increased survival
and greater use of assistive aids and proven
treatments (4–6). It offers the convenience of a
single visit rather than multiple appointments and
may also improve quality of life and reduce hospital
admissions (4,7,8). MDCs are usually centralized
in hospitals and as the patient becomes more
disabled, traveling to often-lengthy appointments
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becomes difficult. Even in developed countries,
attendance at MDCs is not universal (between 43
and 85%), and some patients may only be able to
attend once (9). Community clinicians who pro-
vide care between visits have limited exposure to
this rare disease so lack specialist experience and
this can result in patients and carers experiencing
significant difficulties (10–15). Lack of coordinated
care and advanced planning makes access to
services such as palliative and social care more
difficult (16).
We wanted to improve access to specialist care
during and between clinic visits and maintain an
efficient service and considered whether digital
technology could help. Telehealth systems collect
information about a patient and relay it to the
healthcare provider enabling problems to be
detected and treatments monitored remotely (17).
MND lends itself well to telehealth because moni-
toring relies mainly on assessing a patient’s func-
tion and identifying distressing symptoms (such as
breathlessness), much of which can be self-
reported. Technology-enabled care has been used
in a limited number of MND centers to monitor
respiratory parameters but no system has been
developed to monitor the other features of the
disease (17).
Telehealth is a complex intervention as it
consists of multiple interacting components (18).
Components might include the technology, the way
it is used by patients and clinicians and the service
in which it is embedded. Successful telehealth
relies on each of those interacting processes (18).
Previous trials of telehealth have experienced
difficulties with acceptability and staff and patient
uptake, highlighting the importance of designing
new services with the end-user in mind (19–21).
This reflects the wider experience of new services
where too often, the user-experience is unsatisfac-
tory and this is largely because the technology and
the way we interact with it is designed and
developed in isolation of the service and its users
(22). User-centered co-design is an approach used
for developing new systems or services which
involves end-users in every stage of the develop-
ment process (23). Those who are likely to be
affected by a new intervention or service have the
right to a have a say in what that outcome is and
participatory design helps users influence the
design by offering their experience and unique
perspectives and preferences (23). It also ensures
that the focus remains on the end-user (24). These
approaches have been successfully used in health
service redesign (25–27), to promote self-manage-
ment (for example the Intelligent Shoe in stroke
rehabilitation (28,29)) and in MND (patient-edu-
cation websites (30), and the Head-Up collar
(31)).
Methods
Aims
We aimed to:
 Explore the current MND service, the unmet
needs associated with access to specialist care,
and how the service could be improved;
 Identify opportunities by which technology-
enabled service might be used to improve the
service;
 Use the results to develop the aims, scope, and
content of technology that could be used in the
MND service;
 Perform initial testing with users;
 Explore how the system might be evaluated.
The methods followed the Medical Research
Council framework for development, evaluation,
and implementation of complex interventions (18).
We used a range of iterative techniques occurring in
parallel, using triangulation method to combine
results. Investigator triangulation involved the three
facilitators at the workshops providing written feed-
back all of which was reviewed by EH who then
returned to the transcripts and audio-recordings to
ensure all relevant themes identified were supported
by the data. Data triangulation involved presenting
results from each consultation process to trial
management meetings to allow interpretation by
the broader development team. Methods triangula-
tion involved discussing themes identified from the
early consultation work (informal presentations, the
patient/carer interview, and discussions with clin-
icians) in the workshops to explore the range of ideas
in more detail.
Service-user consultations
We consulted a range of people with experience of
MND. Early ideas were presented at three meetings
of a patient and public involvement group (the
Sheffield MND Research Advisory Group (32)) and
two local MND Association charity meetings. Field
notes were made and feedback was invited in person
and by email. In addition, patient and one carer who
lived at a distance from the MND center underwent
a semi-structured interview using a topic guide
which was audio-recorded, transcribed, and the
themes identified using thematic analysis (33).
These meetings provided early feedback on the
aims and scope of the project and informed the
structure of the workshops that would explore the
questions in more detail.
User-centered design workshops
Two workshops employing user-centered design
techniques were conducted. Participants were
recruited by word-of-mouth through the local
MND Association charity, the MDC, and the
Sheffield MND Research Advisory Group. Three
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males with MND, six carers or ex-carers (five
female, one male), and an MND specialist nurse
took part. Two patients attended with carers (both
attended with their wives and one also brought his
daughter) and one patient attended alone. Two
patients used a wheelchair, one a scooter and all
three had upper limb disabilities. One patient had
speech difficulties but could communicate verbally
with support from his wife.
INVOLVE patient and public involvement guide-
lines were followed (34). Travel expenses, disabled
parking, toilet facilities and refreshments were
provided and carers were encouraged to participate
to support those with MND. The workshops were
facilitated by a clinician (EH), a specialist in user-
centered design (RP) and a telehealth user experi-
ence designer. Time was allowed to ensure all
participants could communicate using whichever
means they preferred. A written feedback question-
naire was provided to participants at the end of the
session. Written consent was obtained. Ethical
approval was not required as the individuals were
acting in an advisory role rather than as research
participants (34).
All workshops were audio-recorded. Field notes
were made independently by the three facilitators
and EH reviewed all the notes and recordings,
transcribed relevant text and produced summary of
each workshop describing the key themes, feedback,
and comments.
The two workshops were conducted as follows.
An icebreaker session used puzzles and games to
introduce the group and established aims and rules of
the workshop. A patient journey mapping exercise
explored participants’ experiences of attending an
MDC appointment, their stories, emotions, and
difficulties with services (Figure 1). Participants
arranged pictures and labels describing the stages of
before, during, and after an MDC. By sharing their
lived experience, this approach has proven successful
as a prompt for further interrogation of the patient
experience (25). Personas (picture and descriptions
of other examples of patients and carers (35))
encouraged consideration for the experiences of
others living with MND. Notes were made placed
on the table to summarize the findings. A round-table
activity involved individual participants explaining
how they would use a tablet computer. This allowed
participants to explain how MND affected them,
their attitudes toward and barriers and enablers to
using technology and telehealth, their experiences of
clinical trials, and how these novel interventions
could be used and tested. To encourage creativity and
avoid constraining participants’ thinking, the pro-
posed telehealth model was not shown to the partici-
pants at this stage. Instead, a cardboard square was
used to represent a basic tablet computer and the
participants were encouraged to explain how they
would like to use or adapt the technology, however,
impractical. This article prototyping uses the ‘‘good
enough’’ model which allows an initial understanding
of complex systems to be shared and experienced by
users (36). Participants tested a wire-frame HTML
click-dummy mimicking an early version of a poten-
tial telehealth patient app. Facilitators could assess its
ease of use and participants’ reactions to the system.
Patients were videoed using the app. Concurrent
think-aloud techniques encouraged participants to
describe their thoughts as they interacted with the
software and concurrent probing was used by facili-
tators to explore their ideas in more detail (37).
Healthcare professional consultations
EH (specialist registrar in neurology) and CM
(consultant neurologist with over 10-year experience
in MND) led the development and consulted a
wider group of clinicians (another MND specialist
neurologist, a specialist neurology registrar, and four
Sheffield MDC nurses/therapists). Results from the
consultations were presented and discussed at
regular meetings which helped refine the aims,
scope, and feasibility of an improved service.
Clinicians later reviewed telehealth content and the
software. To obtain the views of those outside the
MDC, a community specialist MND occupational
therapist underwent an audio-recorded semi-struc-
tured interview. Two home visitors who volunteered
for the Motor Neurone Disease Association
reviewed the Patient App and provided written
feedback. In parallel, reviews of the literature were
conducted to identify existing best practice, the
unmet needs of those living with MND, the poten-
tial uses of digital technology and the barriers and
enablers to a successful service (17,38).
Developing the TiM software
Regular meetings enabled project leads to under-
stand the abilities and limitations of telehealth.
Meanwhile, the telehealth developers learned about
the needs of the service and its users particularly in
the unique context of MND. Specifications of the
telehealth service were defined including:
 The information a clinician gains from a patient
and carer in MDC assessment and how this
could be captured;
 The frequency of monitoring;
 The clinical algorithms which would analyze the
data and alert clinicians to problems;
 The way in which the patient, carer and MND
clinicians would interact with system.
A click dummy was tested during the user
consultations. This meant modification could be
made in response to feedback prior to coding. The
Clinical Portal displaying the patient/carer answers
was then developed and beta-tested by clinicians
who used the software and entered different answers
several times into the app to detect faults in the
software or clinical algorithms.
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Results
The main themes identified in the consultations
with patients, carers, clinicians, and volunteers were:
(1) The importance of coordinated, accessible
MND care;
(2) The desire for information to help people cope
with MND;
(3) The acceptability of telehealth and remote
monitoring;
(4) The value of patient-reported information in
remote monitoring;
(5) The potential impact of telehealth.
1) The importance of coordinated, accessible MND
care
All those consulted felt that there was a need to
improve access to MDC. They identified valuable
aspects of the MDC including access to evidence-
based treatments and trials, monitoring of the
clinical progress (through questions and physical
examination) and the provision of specialist
information.
Without coming to clinic you are left in the dark.
Patient, user-centered design workshop.
The interpersonal aspect of MDC was also
important: participants valued the ability to be able
to talk to experts who could understand and solve
their (often complex) problems as well as provide
empathy and reassurance.
It’s nice to be told you’re doing well. Patient, user-
centered design workshop.
Difficulty accessing care outside the MDC were
also identified. Patients and carers reporting having
to deal with multiple different community health-
care professionals who often lacked the specialist
knowledge and coordination required to manage
MND, particularly for issues unique to neurological
disease, such as wheelchairs, gastrostomy tubes, and
ventilation equipment.
Everything seems to take at least three months to sort
out, which is frustrating. . . There’s nobody that seems
to take control of the situation. Patient, interview.
Carers had to become experts themselves in
order to assume the responsibility for managing
these problems, particularly out-of-hours.
A lot of time you were left on your own. Ex-carer, user-
centered design workshop.
2) The desire for information to help people cope with
MND
Whilst participants relied heavily on healthcare
professionals, all stakeholders felt more information
Figure 1. The results of the two workshops examining a service-users journey to an MDC appointment.
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and signposting should be available to help them
self-manage their condition. Difficulties posed by
the nature of the hospital-based service model
including traveling to MDC (described as stress-
ful and tiring), the inflexible nature of MDC
appointments, and rapidly changing nature of the
disease. This meant patients suffered delays in
identification and treatment of new problems and
worried that a deterioration in their condition could
lead to avoidable emergency hospital admissions.
I waited so long for this special chair that by the time it
arrived I had got worse and couldn’t use it.
Patient, user-centered design workshop.
3) The acceptability of telehealth and remote
monitoring
The principle of telehealth: that is, using patient/
carer questionnaires to enable the MND specialist
team to remotely monitor them was felt to be
acceptable to patients and their carers. Patients
thought that telehealth could reduce the need for
patients to attend the clinic if they were stable and
currently needed no MDC input and could allow
the MDC to remain in contact with those unable to
attend clinic.
4) The value of patient-reported information
We identified problems that could be monitored and
once identified could be addressed by the MDT by
treatment, signposting or education such as:
 Disease progression;
 Complications of MND that might impact on
survival, quality of life, or result in a hospital
admission;
 Problems with specialist equipment;
 Carer difficulties.
5) The potential impact of telehealth
Potential benefits of telehealth identified were
identified. These included earlier management of
problems which might lead to improved clinical
outcomes (quality of life and survival) and reduced
unnecessary health encounters. Better coordination
might mean patients can access the clinician best
placed to address the problem, rather than having to
first consult non-specialist clinicians.
The TiM system
The Telehealth in Motor neurone disease (TiM)
system was developed. A Patient App sends infor-
mation to a Clinical Portal (a website accessible to
the MDC team) (Figure 2). Pre-defined clinical
algorithms assign the information a flag (green,
amber, and red). Clinicians can review the answers
and initiate interventions as required. Information is
transferred anonymously using only the device IMEI
identifier and stored on a secure server using two-
factor identification access. The TiM system was
not designed to manage emergency situations: a
message at the end of the TiM session reminds the
user to contact a healthcare professional in these
circumstances.
The Patient App
The Patient App is an Android software application
designed to be used on a 7-inch tablet computer
(Figure 3). It asks patients and their carer a series of
weekly questions. Additional questions appear if
patients use non-invasive ventilation, a gastrostomy
or report complications. The questions cover all
aspects of MND: ‘‘Arms and Legs’’, ‘‘Speech and
swallow’’, ‘‘Breathing’’, ‘‘Wellbeing’’ and
‘‘Nutrition’’. Some questions closely match vali-
dated scoring scales (for example the depression and
anxiety short screening tool PHQ-4 or the ALS
functional rating scale (39,40)). Other questions
were designed for the TiM using direct questions or
symptom severity scales (Figure 3). Carers have
separate questions which are accessed through a
separate login assessing carer strain, depression, and
anxiety. The TiM also receives data from Wi-Fi-
enabled scales collecting weight and a measure of
standing balance. Additional physical biomarkers
(such as blood pressure or pulse oximeter) were not
included because the team concluded that their
value to routine MND care was limited.
The Clinical Portal
Information from the Patient App is immediately
uploaded to the internet and displayed on a web-
based Clinical Portal for MDC clinicians (Figure 4).
A flag (red, amber, and green) is generated for each
question based on predefined clinical algorithms.
Flags highlight significant or sustained changes in
the patient/carer condition or the presence of serious
complications (such as choking). The portal displays
a summary for each patient and carer, all flags
raised, and individual answers from each question.
Additions were added later: a ‘‘Heatmap’’ page
which provides a visual display of historical flags and
trends in scores (ALS-FRS-R, weight, balance, and
carer strain) (Figure 5) and a facility to review the
previous six answers and pause flags (Figure 6).
The impact of user-centered design on the TiM
The user-centered design workshop participants all
agreed that they could make their opinions heard
and that they would attend another event. One liked
‘‘the interactive element, stimulated lots of discus-
sion’’, another thought the session was ‘‘very
informative and good to be involved in research’’.
The participatory design process influenced TiM
development. Participants reported a strong desire
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Figure 3. The TiM patient app. Questions include those measuring function (top) and symptoms (middle) with educational message
placed between questions (bottom).
Figure 2. The TiM system.
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to learn more about the disease to help people cope
so we added screens in the app providing signpost-
ing and information about self-management (Figure
3) and a section to enable patients to record
problems they wish to discuss. Developers observed
patients with upper limb weakness and fatigue using
the software and understood how this impacted on
the use of the app. As a result, the touch-screen
layout was redesigned to reduce the amount of hand
movement that was required to complete the ques-
tionnaire. The usability testing later demonstrated
that the Patient App could be completed quickly,
even by those with moderate arm weakness or
fatigue.
The consultations explored whether using tele-
health to assess sensitive topics was likely to be
acceptable. Clinicians were concerned that patients
would be distressed if presented with answers that
described the most severe stages of MND (such as
being unable to swallow). However, patients and
carers welcomed the thorough assessment of the
impact of MND on their lives and confirmed that
they were happy to answer questions on sensitive
topics. They explained they were already aware of
the implications of MND and that they were not
distressed by seeing the full range of answers.
Furthermore, they preferred to see all the possible
answers because they thought that presenting only a
limited number of options might make them give
incorrect answers. In response, we changed the
question structure to include all possible answers
(see Figure 3 for an example). This had the added
benefit of reducing the total number of questions
thus shortening the time taken to complete the TiM
system.
Discussion
There is clear evidence that specialist MND care
brings benefits to patients but all participants in this
project felt that access to this care needs to be
improved. This early work has established ways in
which technology could be used to improve MND
care by facilitating monitoring, communication and
care coordination, and this could offer improved
outcomes. Despite their frailty, our participants
highlighted their desire to learn about and self-
manage their disease and telehealth offers the
opportunity to improve health literacy, shared deci-
sion making, and self-management (which might be
associated with improved self-efficacy (41)). Self-
management programs are being promoted as a
cost-effective response to the challenges imposed by
a population with increasing age and co-morbidities
(22). This is particularly relevant to MND given the
prospect of new therapies that prolong survival
meaning pressure on the already limited MND
services will increase. Telehealth may be even more
vital in countries with more highly dispersed popu-
lations or in resource-poor areas where patients do
Figure 4. The Clinical Portal displaying individual patient information.
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not have the means to travel to regional centers.
These services may also compliment other forms of
technology-enabled care, such as video consult-
ations which are already used in some MDCs
(17,42,43).
Our experience demonstrates the benefits of
user-centered co-design. The use of creative visual
methods enabled rich conversations between diverse
groups (44). Capturing the current and desired
experiences of users helped us understand what is
important to an MND service and what could be
improved. Involving clinicians meant the system
retained focus on delivering evidence-based best-
practice within the constraints of the real-world
setting. Enabling developers to work with patients
and carers meant they had a better understanding of
the difficulties faced by those with MND and could
work together to modify and test solutions. An
unexpected benefit of this collaboration was that
participants were also able to allay clinicians’ con-
cerns about using technology to assess sensitive
problems. Finally, as was previously observed when
developing the Head-Up collar (31), we hope that
co-design participants will become advocates of
the product, increasing the likelihood of wider
‘‘buy-in’’.
Limitations
This project involved a small number of those with
experience of MND, most of whom only had
experience of the Sheffield MDC. However, it did
include other participants who had not attended an
MDC or who faced barriers to access. Crucially, it
involved participants with years of experience
Figure 5. Clinical Portal Heatmap.
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visiting families living with MND. They provided
insights into the views of less-heard groups, such as
those who could no longer attend clinic. This
project has stimulated further research that sug-
gested that the positive attitudes to technology are
shared with a larger sample of patients and carers
(45). The major limitation of designing of a digital
product is the need to for multiple changes. There
are time and financial constraints to development,
particularly when involving users in the way we did.
Whilst our iterative design process did allow changes
to be made to the scope and content of the service
before the technology was coded, after that time,
changes become more difficult to implement. The
rapid improvement in technology and changes in the
health service itself mean improved and upgrades
must be planned at each stage of the design process.
The TiM system now needs to be evaluated in a
real-life setting. This project helped identify some of
the uncertainties that need addressing including how
the TiM system will be used in real-life, the use by
those facing barriers, such as severe disability or a
lack of digital literacy and the impact TiM has on
users and the service itself. This project identified
some aspects of MND care that are important to
patients and clinicians but are difficult to recreate
using digital technology (such as interpersonal rela-
tionships and physical examinations) and future
evaluations should address whether telehealth can
deliver a good standard of care despite these con-
straints. Evaluations should not only aim to measure
the impact of the TiM but should also help establish
how a successful telehealth service could be widely
implemented by exploring the processes that occur
during service change and identifying the barriers
and facilitators to service improvement (46,47).
Conclusion
We used user-centered design to develop a novel
system which could facilitate access to specialist
care. It is strongly recommended that this approach
involving all those involved in the receipt and
delivery of care are used whenever a new interven-
tion or service is developed in order to increase the
chances of success.
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